117 related articles for article (PubMed ID: 30257327)
21. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.
Russo RC; Garcia CC; Teixeira MM; Amaral FA
Expert Rev Clin Immunol; 2014 May; 10(5):593-619. PubMed ID: 24678812
[TBL] [Abstract][Full Text] [Related]
22. CXCL1 and CXCL2 Regulate NLRP3 Inflammasome Activation via G-Protein-Coupled Receptor CXCR2.
Boro M; Balaji KN
J Immunol; 2017 Sep; 199(5):1660-1671. PubMed ID: 28739876
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of recombinant human CXCL8(3-72)K11R/G31P on atherosclerotic plaques in a mouse model of atherosclerosis.
Qin Y; Mao W; Pan L; Sun Y; Fan F; Zhao Y; Cui Y; Wei X; Kohama K; Li F; Gao Y
Immunopharmacol Immunotoxicol; 2019 Jun; 41(3):446-454. PubMed ID: 31124391
[No Abstract] [Full Text] [Related]
24. IL-8 analogue CXCL8 (3-72) K11R/G31P, modulates LPS-induced inflammation via AKT1-NF-kβ and ERK1/2-AP-1 pathways in THP-1 monocytes.
Walana W; Wang JJ; Yabasin IB; Ntim M; Kampo S; Al-Azab M; Elkhider A; Dogkotenge Kuugbee E; Cheng JW; Gordon JR; Li F
Hum Immunol; 2018 Nov; 79(11):809-816. PubMed ID: 30125599
[TBL] [Abstract][Full Text] [Related]
25. Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2.
Maeda DY; Peck AM; Schuler AD; Quinn MT; Kirpotina LN; Wicomb WN; Fan GH; Zebala JA
J Med Chem; 2014 Oct; 57(20):8378-97. PubMed ID: 25254640
[TBL] [Abstract][Full Text] [Related]
26. ELR-CXC chemokine antagonism is neuroprotective in a rat model of ischemic stroke.
Connell BJ; Gordon JR; Saleh TM
Neurosci Lett; 2015 Oct; 606():117-22. PubMed ID: 26320021
[TBL] [Abstract][Full Text] [Related]
27. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
[TBL] [Abstract][Full Text] [Related]
28. A novel ELR-CXC chemokine antagonist reduces intestinal ischemia reperfusion-induced mortality, and local and remote organ injury.
Zhao X; Town JR; Yang A; Zhang X; Paur N; Sawicki G; Gordon JR
J Surg Res; 2010 Aug; 162(2):264-73. PubMed ID: 19691980
[TBL] [Abstract][Full Text] [Related]
29. Emodinol ameliorates urate nephropathy by regulating renal organic ion transporters and inhibiting immune inflammatory responses in rats.
Wu H; Zhou M; Lu G; Yang Z; Ji H; Hu Q
Biomed Pharmacother; 2017 Dec; 96():727-735. PubMed ID: 29045935
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
[TBL] [Abstract][Full Text] [Related]
31. Study of hispidulin in the treatment of uric acid nephropathy based on NF-κB signaling pathway.
Li X; Gu Y; Ren L; Cai Q; Qiu Y; He J; Qu W; Ji W
Chem Biol Drug Des; 2024 Jan; 103(1):e14367. PubMed ID: 37880153
[TBL] [Abstract][Full Text] [Related]
32. Neutrophils recruited by CXCR1/2 signalling mediate post-incisional pain.
Carreira EU; Carregaro V; Teixeira MM; Moriconi A; Aramini A; Verri WA; Ferreira SH; Cunha FQ; Cunha TM
Eur J Pain; 2013 May; 17(5):654-63. PubMed ID: 23132735
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of recombinant CXCL8(3-73)K11R/G31P in muscle fibrosis and Trichinella larvae encapsulation in a murine model of trichinellosis.
Yan W; Li F; Qin Y; Ren Y; Zheng L; Dai X; Mao W; Cui Y
Int Immunopharmacol; 2016 Jun; 35():323-326. PubMed ID: 27089392
[TBL] [Abstract][Full Text] [Related]
34. 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists.
Biju P; Taveras A; Yu Y; Zheng J; Chao J; Rindgen D; Jakway J; Hipkin RW; Fossetta J; Fan X; Fine J; Qiu H; Merritt JR; Baldwin JJ
Bioorg Med Chem Lett; 2008 Jan; 18(1):228-31. PubMed ID: 18006311
[TBL] [Abstract][Full Text] [Related]
35. Cloning and characterization of guinea pig CXCR1.
Takahashi M; Jeevan A; Sawant K; McMurray DN; Yoshimura T
Mol Immunol; 2007 Feb; 44(5):878-88. PubMed ID: 16712933
[TBL] [Abstract][Full Text] [Related]
36. DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain.
Lopes AH; Brandolini L; Aramini A; Bianchini G; Silva RL; Zaperlon AC; Verri WA; Alves-Filho JC; Cunha FQ; Teixeira MM; Allegretti M; Cunha TM
Pharmacol Res; 2016 Jan; 103():69-79. PubMed ID: 26592483
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells.
Liotti F; Collina F; Pone E; La Sala L; Franco R; Prevete N; Melillo RM
Stem Cells; 2017 Jan; 35(1):135-146. PubMed ID: 27577959
[TBL] [Abstract][Full Text] [Related]
38. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2.
Moriconi A; Cesta MC; Cervellera MN; Aramini A; Coniglio S; Colagioia S; Beccari AR; Bizzarri C; Cavicchia MR; Locati M; Galliera E; Di Benedetto P; Vigilante P; Bertini R; Allegretti M
J Med Chem; 2007 Aug; 50(17):3984-4002. PubMed ID: 17665889
[TBL] [Abstract][Full Text] [Related]
39. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human CXCL8(3-72)K11R/G31P regulates smooth muscle cell proliferation and migration through blockage of interleukin-8 receptor.
Qin Y; Fan F; Zhao Y; Cui Y; Wei X; Kohama K; Gordon JR; Li F; Gao Y
IUBMB Life; 2013 Jan; 65(1):67-75. PubMed ID: 23281038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
